The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements

Autor: McCreary, Andrew C., Varney, Mark A., Newman-Tancredi, Adrian
Zdroj: In Neuropharmacology June 2016 105:651-660
Databáze: ScienceDirect